140 related articles for article (PubMed ID: 16409424)
1. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
Tsai CC; Pei D; Hung YJ; Wang TF; Tsai WC; Yao CY; Hsieh MC; Kuo SW
Int J Clin Pract; 2006 Jan; 60(1):23-6. PubMed ID: 16409424
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of thyroxine-suppressive therapy and its relation to serum thyroglobulin levels in solitary nontoxic thyroid nodules.
Kuo SW; Hu CA; Pei D; Ni KB; Shian LR
J Formos Med Assoc; 1993 Jan; 92(1):55-60. PubMed ID: 8099828
[TBL] [Abstract][Full Text] [Related]
3. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
Wémeau JL; Caron P; Schvartz C; Schlienger JL; Orgiazzi J; Cousty C; Vlaeminck-Guillem V
J Clin Endocrinol Metab; 2002 Nov; 87(11):4928-34. PubMed ID: 12414852
[TBL] [Abstract][Full Text] [Related]
4. Levothyroxine suppressive therapy is partially effective in treating patients with benign, solid thyroid nodules and multinodular goiters.
Lima N; Knobel M; Cavaliere H; Sztejnsznajd C; Tomimori E; Medeiros-Neto G
Thyroid; 1997 Oct; 7(5):691-7. PubMed ID: 9349571
[TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules.
Papini E; Bacci V; Panunzi C; Pacella CM; Fabbrini R; Bizzarri G; Petrucci L; Giammarco V; La Medica P; Masala M
Clin Endocrinol (Oxf); 1993 May; 38(5):507-13. PubMed ID: 8330445
[TBL] [Abstract][Full Text] [Related]
6. Suppressive therapy with levothyroxine for solitary thyroid nodules. A double-blind controlled clinical study.
Gharib H; James EM; Charboneau JW; Naessens JM; Offord KP; Gorman CA
N Engl J Med; 1987 Jul; 317(2):70-5. PubMed ID: 3295553
[TBL] [Abstract][Full Text] [Related]
7. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
Zelmanovitz F; Genro S; Gross JL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3881-5. PubMed ID: 9814462
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of solitary toxic thyroid nodules with the use of percutaneous ethanol injections].
Bartos M; Kuzdak K; Kukulski K; Narebski J; Pomorski L
Wiad Lek; 2000; 53(1-2):22-9. PubMed ID: 10806916
[TBL] [Abstract][Full Text] [Related]
9. Effect of percutaneous ethanol injection therapy versus suppressive doses of L-thyroxine on benign solitary solid cold thyroid nodules: a randomized trial.
Bennedbaek FN; Nielsen LK; Hegedüs L
J Clin Endocrinol Metab; 1998 Mar; 83(3):830-5. PubMed ID: 9506736
[TBL] [Abstract][Full Text] [Related]
10. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule].
Gołkowski F; Jabrocka-Hybel A; Huszno B
Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials.
Sdano MT; Falciglia M; Welge JA; Steward DL
Otolaryngol Head Neck Surg; 2005 Sep; 133(3):391-6. PubMed ID: 16143188
[TBL] [Abstract][Full Text] [Related]
12. [Current views on diagnostic standards and treatments with L-thyroxine of single non-toxic thyroid nodules or multinodular non-toxic goiter].
Lewiński A
Wiad Lek; 2001; 54 Suppl 1():21-30. PubMed ID: 12182027
[TBL] [Abstract][Full Text] [Related]
13. Changes in both size and cytological features of thyroid nodule after levothyroxine treatment.
Vermiglio F; Lo Presti VP; Violi MA; Moleti M; Castagna MG; Finocchiaro MD; Mattina F; Mandolfino M; Zimbaro G; Trimarchi F
Clin Endocrinol (Oxf); 2003 Sep; 59(3):347-53. PubMed ID: 12919158
[TBL] [Abstract][Full Text] [Related]
14. Effect of low- and high-dose levothyroxine on thyroid nodule volume: a crossover placebo-controlled trial.
Koc M; Ersoz HO; Akpinar I; Gogas-Yavuz D; Deyneli O; Akalin S
Clin Endocrinol (Oxf); 2002 Nov; 57(5):621-8. PubMed ID: 12390336
[TBL] [Abstract][Full Text] [Related]
15. [Benign thyroid nodules in the elderly. Medical treatment].
Cramarossa I; Caruso AA; Morena L; Salandri A
Minerva Endocrinol; 1998 Sep; 23(3):77-82. PubMed ID: 10063325
[TBL] [Abstract][Full Text] [Related]
16. [Therapy with L-thyroxine in thyroid struma. Study with ultrasonic evaluation].
Peta M; Cartasegna S; Fabiani MP; Macchi R; Vecchi G; Costantino D
Recenti Prog Med; 1989 Jun; 80(6):320-5. PubMed ID: 2672195
[TBL] [Abstract][Full Text] [Related]
17. Levothyroxine suppressive therapy for solitary thyroid nodule.
Mainini E; Martinelli I; Morandi G; Villa S; Stefani I; Mazzi C
J Endocrinol Invest; 1995 Nov; 18(10):796-9. PubMed ID: 8787957
[TBL] [Abstract][Full Text] [Related]
18. [Levothyroxine treatment of the solitary thyroid nodule].
Almodóvar Ruiz F; Maldonado Castro G; de Luis D; Lahera M; Varela da Costa C
An Med Interna; 2000 Feb; 17(2):99-101. PubMed ID: 10829467
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial.
Eustatia-Rutten CF; Corssmit EP; Pereira AM; Frölich M; Bax JJ; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Mar; 64(3):284-91. PubMed ID: 16487438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
